Production of tumor necrosis factor-alpha and lymphotoxin by cells of Hodgkin's neoplastic cell lines HDLM-1 and KM-H2
- PMID: 2801887
- PMCID: PMC1880038
Production of tumor necrosis factor-alpha and lymphotoxin by cells of Hodgkin's neoplastic cell lines HDLM-1 and KM-H2
Abstract
The production of tumor necrosis factors (TNF) from cells of two Hodgkin's Reed-Sternberg (H-RS) lines, HDLM-1 and KM-H2 was examined. The culture supernatant from these two types of H-RS cells exerts a cytotoxic effect on L929 cells. Both tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) are responsible for this activity. This was confirmed by the presence in the cells of proteins and m-RNAs of TNF-alpha and TNF-beta, as determined with immunoperoxidase staining and Northern blot hybridization. Approximately 20% of HDLM cells and 5% of KM-H2 cells were positively stained by a monoclonal anti-TNF-alpha antibody, and this staining was inhibited by preabsorption of the antibody with recombinant TNF-alpha. Staining with anti-TNF-beta, however, showed an intense reaction in more than 60% of HDLM-1 cells, but only in 5% to 10% of KM-H2 cells. The abundant expression of TNF-beta in HDLM-1 cells is consistent with approximately 10 times the TNF activity in HDLM-1-conditioned medium as compared with that of KM-H2. The rich secretion of TNF-beta in HDLM-1 cells was also validated by the inhibition of most of the TNF activity in HDLM-1-conditioned medium with anti-TNF-beta antibody, and by the presence of abundant TNF-beta mRNA in HDLM-1 cells. The reason for the abundant production of TNF-beta in HDLM-1 cells is not yet known, but may be attributable to a chromosomal abnormality in the 6p21 region. The expression of TNF-alpha, but not TNF-beta, by H-RS cells was demonstrated in lymph nodes from patients with Hodgkin's disease. The capacity of H-RS cells to secrete TNF as well as other cytokines, such as interleukin-1, colony-stimulating factors, and transforming growth factors, may contribute to the unique clinical and histopathologic alterations in patients with Hodgkin's disease.
Similar articles
-
Tumor necrosis factor alpha and lymphotoxin production in Hodgkin's disease.Am J Pathol. 1990 Aug;137(2):341-51. Am J Pathol. 1990. PMID: 2386200 Free PMC article.
-
Expression of macrophage colony-stimulating factor (M-CSF) in two Hodgkin's Reed-Sternberg (H-RS) cell lines, HDLM-1 and KM-H2, and in H-RS cells in tissues.Int J Hematol. 1991 Aug;54(4):315-26. Int J Hematol. 1991. PMID: 1838015
-
Abundant expression of transforming growth factor-beta 1 and -beta 2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease.Hum Pathol. 1993 Mar;24(3):249-55. doi: 10.1016/0046-8177(93)90034-e. Hum Pathol. 1993. PMID: 7681031
-
Hodgkin's disease derived cell lines: a review.Hum Cell. 1992 Mar;5(1):42-53. Hum Cell. 1992. PMID: 1419951 Review.
-
Human tumour necrosis factors: structure and receptor interactions.Ciba Found Symp. 1987;131:39-51. doi: 10.1002/9780470513521.ch4. Ciba Found Symp. 1987. PMID: 2836139 Review.
Cited by
-
Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.Am J Pathol. 1990 Nov;137(5):1163-71. Am J Pathol. 1990. PMID: 1700619 Free PMC article.
-
Transforming growth factor beta 1 messenger RNA in Reed-Sternberg cells in nodular sclerosing Hodgkin's disease.J Clin Pathol. 1995 Feb;48(2):160-3. doi: 10.1136/jcp.48.2.160. J Clin Pathol. 1995. PMID: 7745117 Free PMC article.
-
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.Br J Cancer. 1998 Mar;77(6):992-7. doi: 10.1038/bjc.1998.163. Br J Cancer. 1998. PMID: 9528846 Free PMC article.
-
Cultured Reed-Sternberg cells HDLM-1 and KM-H2 can be induced to become histiocytelike cells. H-RS cells are not derived from lymphocytes.Am J Pathol. 1990 Aug;137(2):353-67. Am J Pathol. 1990. PMID: 2167011 Free PMC article.
-
Hodgkin Lymphoma-Derived Extracellular Vesicles Change the Secretome of Fibroblasts Toward a CAF Phenotype.Front Immunol. 2018 Jun 18;9:1358. doi: 10.3389/fimmu.2018.01358. eCollection 2018. Front Immunol. 2018. PMID: 29967610 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical